Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines

All NewsMarch 23, 2026

California-based drugmaker takes advantage of surging share price to strike takeovers after a quiet couple of years

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent